Literature DB >> 9495539

Structure-function relationship of different domains of the rat corticotropin-releasing factor receptor.

S Sydow1, J Radulovic, F M Dautzenberg, J Spiess.   

Abstract

The significance of different domains of corticotropin-releasing factor receptor, type 1, (CRFR1) for ligand binding and cAMP accumulation was investigated with C-terminally truncated forms of rat CRFR1 (rCRFR1) tagged by a sequence of six histidine residues (His-tag) to facilitate protein purification and identification. These different forms of the receptor were N-glycosylated and transported properly to the membranes of transfected mammalian cells as indicated by Western blot analysis and immunocytochemical staining with two polyclonal antibodies developed against the N- and C-terminus of rCRFR1. The N-terminal fragment, rCRFR1(23-121), expressed in Escherichia coli bound oCRF specifically, but with low affinity. Several mutants lacking transmembrane domain (TM) 7 and the C-terminus exhibited similarly low affinities to oCRF after expression in transfected mammalian cells. None of these cells produced significant amounts of cAMP after exposure to oCRF. Only mutants containing the N-terminus, all loops and TMs bound oCRF and produced cAMP with high affinity (Kd = 62 nM) and efficacy (EC50 = 0.8 nM). The additional presence of the C-terminus provided similar characteristics (Kd = 5 nM, EC50 = 0.3 nM) as known for the native receptor. It is suggested on the basis of these data that the last extracellular loop is involved in ligand binding.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9495539     DOI: 10.1016/s0169-328x(97)00256-8

Source DB:  PubMed          Journal:  Brain Res Mol Brain Res        ISSN: 0169-328X


  9 in total

1.  CRH functions as a growth factor/cytokine in the skin.

Authors:  A Slominski; B Zbytek; A Pisarchik; R M Slominski; M A Zmijewski; J Wortsman
Journal:  J Cell Physiol       Date:  2006-03       Impact factor: 6.384

2.  Molecular cloning and initial characterization of African green monkey (Cercopithecus aethiops) corticotropin releasing factor receptor type 1 (CRF1) from COS-7 cells.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Alexander Pisarchik; Jacobo Wortsman
Journal:  Gene       Date:  2006-11-10       Impact factor: 3.688

Review 3.  Emerging role of alternative splicing of CRF1 receptor in CRF signaling.

Authors:  Michał A Zmijewski; Andrzej T Slominski
Journal:  Acta Biochim Pol       Date:  2010-03-16       Impact factor: 2.149

4.  Functional and protein chemical characterization of the N-terminal domain of the rat corticotropin-releasing factor receptor 1.

Authors:  B A Hofmann; S Sydow; O Jahn; L van Werven; T Liepold; K Eckart; J Spiess
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

5.  A single amino acid serves as an affinity switch between the receptor and the binding protein of corticotropin-releasing factor: implications for the design of agonists and antagonists.

Authors:  K Eckart; O Jahn; J Radulovic; H Tezval; L van Werven; J Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-25       Impact factor: 11.205

6.  Cortagine, a specific agonist of corticotropin-releasing factor receptor subtype 1, is anxiogenic and antidepressive in the mouse model.

Authors:  Hossein Tezval; Olaf Jahn; Cedomir Todorovic; Astrid Sasse; Klaus Eckart; Joachim Spiess
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-10       Impact factor: 11.205

Review 7.  Key role of CRF in the skin stress response system.

Authors:  Andrzej T Slominski; Michal A Zmijewski; Blazej Zbytek; Desmond J Tobin; Theoharis C Theoharides; Jean Rivier
Journal:  Endocr Rev       Date:  2013-08-12       Impact factor: 19.871

8.  CRF1 receptor splicing in epidermal keratinocytes: potential biological role and environmental regulations.

Authors:  Michal A Zmijewski; Andrzej T Slominski
Journal:  J Cell Physiol       Date:  2009-03       Impact factor: 6.384

9.  Dimerization between vasopressin V1b and corticotropin releasing hormone type 1 receptors.

Authors:  Sharla F Young; Cristiana Griffante; Greti Aguilera
Journal:  Cell Mol Neurobiol       Date:  2007-02-21       Impact factor: 4.231

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.